Furthermore, we observed that patients with CNTNAP5 mutations exhibited a marginally poorer disease‐free survival (DFS) than nonmutated samples (Log‐rank p = 0.088) (Figure S2D), underscoring the gene's potential significance in CRC carcinogenesis. Here, CNTNAP5 is linked to colorectal carcinoma.